CONCORDIA RX

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 May 2024 filing date already counts against anyone who files later.

Record

Serial number

98553736

Mark type

Design + words

Filed

16 May 2024

Published for opposition

24 Mar 2026

Attorney of record

Caroline Duncan

Goods and services

• Class 005 — Pharmaceuticals: a full line of pharmaceuticals for the treatment of depression, malaria, benign prostatic hyperplasia, partial seizures in adults with epilepsy, heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute enterocolitis, and duodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids)

Owner

• Concordia Pharmaceuticals Inc., S.à.r.L, Luxembourg, LU
• Concordia Pharmaceuticals Inc., S.à.r.L, Luxembourg, LU

Prosecution history

• 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Mar 2026 — PUBLISHED FOR OPPOSITION
• 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 27 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 27 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
• 27 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 27 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
• 27 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
• 10 Feb 2026 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 26 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 23 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 23 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 23 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 23 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED